María De Arcocha-Torres
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
María De Arcocha-Torres has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
J.M. Carril
Servicio de Medicina Nuclear, Hospital Universitario Marqués de Valdecilla, Universidad de Cantabria, Santander, Spain
4 shared publicationsP. Medina-Quiroz
Servicio de Medicina Nuclear, Hospital Universitario Marqués de Valdecilla, Universidad de Cantabria, Santander, Spain
4 shared publications- Isabel Martínez-Rodríguez
University of Cantabria
3 shared publications E. Rodríguez
University of Cantabria
2 shared publicationsF. Ortega
University of Cantabria
2 shared publicationsH. Portilla-Quattrociocchi
Servicio de Medicina Nuclear, Hospital Universitario Marqués de Valdecilla, Universidad de Cantabria, Santander, Spain
2 shared publications
Latest Publications
- Open Access
- 30 September 2016
- Published by MDPI AG in Diagnostics
- Vol. 6 (4) , 36
The Role of PET/CT Molecular Imaging in the Diagnosis of Recurrence and Surveillance of Patients Treated for Non-Small Cell Lung Cancer
Non-small cell lung cancer (NSCLC) is the leading cause of cancer mortality worldwide and its prognosis remains poor. Molecular imaging with 18F-FDG PET/CT can metabolically characterize the nature of lesions as benign or malignant, allowing a better staging at the diagnosis of this kind of patient. This advantage can also be applied in the re-staging due to the suspicion of recurrent disease. Many patients have a recurrence of the disease, including surgically treated patients. In the current context, with new personalized oncological treatments, the surveillance for recurrence and its accurate diagnosis are crucial to improve their survival. In this paper, we revise the current knowledge about the clinical and molecular factors related to the recurrent disease. In the context of new, promising, available personalized treatments, the role of molecular imaging with PET/CT and 18F-FDG and non-18F-FDG radiotracers in the follow-up of NSCLC-treated patients is especially attractive and interesting.
- 30 September 2016
- Published by MDPI AG in Diagnostics
- Vol. 6 (4) , 36
Open AccessThe Role of PET/CT Molecular Imaging in the Diagnosis of Recurrence and Surveillance of Patients Treated for Non-Small Cell Lung Cancer
Non-small cell lung cancer (NSCLC) is the leading cause of cancer mortality worldwide and its prognosis remains poor. Molecular imaging with 18F-FDG PET/CT can metabolically characterize the nature of lesions as benign or malignant, allowing a better staging at the diagnosis of this kind of patient. This advantage can also be applied in the re-staging due to the suspicion of recurrent disease. Many patients have a recurrence of the disease, including surgically treated patients. In the current context, with new personalized oncological treatments, the surveillance for recurrence and its accurate diagnosis are crucial to improve their survival. In this paper, we revise the current knowledge about the clinical and molecular factors related to the recurrent disease. In the context of new, promising, available personalized treatments, the role of molecular imaging with PET/CT and 18F-FDG and non-18F-FDG radiotracers in the follow-up of NSCLC-treated patients is especially attractive and interesting.
- 29 February 2012
- Published by Elsevier in Revista Española de Medicina Nuclear e Imagen Molecular (English Edition)
- Vol. 31 (1) , 51-57
Current Status of the Use of 18F-Sodium Fluoride in Bone Disease
- 29 February 2012
- Published by Elsevier in Revista Española de Medicina Nuclear e Imagen Molecular (English Edition)
- Vol. 31 (1) , 51-57
Current Status of the Use of 18F-Sodium Fluoride in Bone Disease
- 1 January 2012
- Published by Elsevier in Revista Española de Medicina Nuclear e Imagen Molecular
- Vol. 31 (1) , 51-57
Estado actual del uso del (18F)fluoruro sódico en la patología ósea
- 1 January 2012
- Published by Elsevier in Revista Española de Medicina Nuclear e Imagen Molecular
- Vol. 31 (1) , 51-57
Estado actual del uso del (18F)fluoruro sódico en la patología ósea
- 31 October 2011
- Published by Elsevier in Revista Española de Medicina Nuclear (English Edition)
- Vol. 30 (5) , 301-306
Molecular Neuroimaging in the Study of Cognitive Impairment: Contribution of the Cerebral Blood Flow SPECT with 99mTc-HMPAO and 18F-FDG PET/CT Scan
- 31 October 2011
- Published by Elsevier in Revista Española de Medicina Nuclear (English Edition)
- Vol. 30 (5) , 301-306
Molecular Neuroimaging in the Study of Cognitive Impairment: Contribution of the Cerebral Blood Flow SPECT with 99mTc-HMPAO and 18F-FDG PET/CT Scan
- 1 September 2011
- Published by Elsevier in Revista Española de Medicina Nuclear
- Vol. 30 (5) , 301-306
La neuroimagen molecular en el estudio del deterioro cognitivo: contribución de la SPECT de perfusión cerebral con 99mTc-HMPAO y la 18F-FDG PET/TAC
- 1 September 2011
- Published by Elsevier in Revista Española de Medicina Nuclear
- Vol. 30 (5) , 301-306
La neuroimagen molecular en el estudio del deterioro cognitivo: contribución de la SPECT de perfusión cerebral con 99mTc-HMPAO y la 18F-FDG PET/TAC